Seven Bridges Announces Strategic Advisory Board Appointments prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
By Terence P. Jeffrey | March 2, 2021 | 3:25pm EST
Eric Lander, nominee for director of the Office of Science and Technology Policy, speaks after being nominated by President Joe Biden at the Queen Theater in Wilmington, Del., Jan. 16, 2021. (Photo by ANGELA WEISS/AFP via Getty Images)
(CNSNews.com) - Eric Lander, whom President Joe Biden has nominated to be director of the Office of Science and Technology Policy, has opposed actually editing the genes of human embryos while repeatedly advocating as an alternative to gene editing the creation of embryos through in vitro fertilization (IVF), using preimplantation diagnostics (PGD) to determine whether an embryo has a genetic defect or disease and then implanting in the mother’s womb only those who do not.
Biden s Top Science Nominee Advocated Preimplantation Genetic Testing to Decide Which Human Embryo to Keep cnsnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnsnews.com Daily Mail and Mail on Sunday newspapers.
Animation Review: The Human Pangenome
Appeared in BioNews 1085
When the Human Genome Project was completed in 2000, Bill Clinton, then president of the United States, called it the most important, most wondrous map ever produced by humankind . This seemed undisputable at the time, for the completion of this research was a true triumph of science and technology and seemed poised to help scientists uncover countless secrets about our species.
To a certain extent this goal has been achieved, as an increased understanding of human sequence variation has allowed the roots of genetic diseases to be investigated, and the technology developed in the original project has allowed for the completion of further landmark projects that have enhanced the practice of medicine, such as The Cancer Genome Atlas. But is this only a glimmer of the true potential of a reference genome?
NHGRI appoints Oleg Shchelochkov as intramural training program director
SHARE:
Dr. Shchelochkov will oversee the research training, fellowship and residency programs at the institute.
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has appointed Oleg Shchelochkov, M.D., as the new director of Clinical and Laboratory Residencies and Fellowships.
Dr. Shchelochkov, a clinical geneticist and medical biochemical geneticist, takes the position with over a decade of experience teaching and training young professionals. He has been part of the NHGRI research community since 2015, starting as a staff clinician. Until recently, he was an associate research physician studying many aspects of organic acidemias.